A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors
A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors
Recruiting · NCT07077434 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess Safety, Tolerability and Drug Levels of Navlimetostat (BMS-986504) in Participants With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-06-03 | NCT07077434 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Fujian Cancer Hospital | Fuzhou | China | 109 |
| Guangdong Provincial People's Hospital | Guangzhou | China | 25 |
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Kanagawa cancer center | Yokohama | Japan | 18 |
| National Cancer Center Hospital | Chuo-ku | Japan | 67 |
| Peking University Shenzhen Hospital | Shenzhen | China | 68 |
| Shandong Cancer Hospital | Jinan | China | 86 |
| Shizuoka Cancer Center | Sunto-gun | Japan | 17 |
| The Cancer Institute Hospital of JFCR | Koto-ku | Japan | 25 |
| The First Affiliated Hospital of Xinxiang Medical University | Xinxiang | China | 16 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 58 |